Hongjin Chu Selected Research

Parenteral Infusions

1/2017	Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.
3/2016	Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongjin Chu Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2017
3	Adenocarcinoma 01/2021 - 06/2015
2	Carcinogenesis 01/2021 - 06/2015
2	Malignant Pleural Effusion 01/2017 - 03/2016
2	Ascites 01/2017 - 03/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Albuminuria 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Pulmonary Hypertension 01/2017
1	Lymphatic Metastasis 01/2017
1	Pericardial Effusion 01/2017
1	Pure Red-Cell Aplasia 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Thymoma (Thymic Carcinoma) 01/2017
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2017
1	Left Ventricular Dysfunction 01/2017
1	Cardiotoxicity 01/2017
1	Signet Ring Cell Carcinoma 06/2015
1	Neoplasm Metastasis (Metastasis) 06/2015
1	Stomach Neoplasms (Stomach Cancer) 06/2015
1	Breast Neoplasms (Breast Cancer) 12/2014
1	Priapism 11/2014
1	Brain Neoplasms (Brain Tumor) 11/2014

Drug/Important Bio-Agent (IBA)

2	Bevacizumab (Avastin)FDA Link 01/2017 - 03/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 03/2016
1	GlypicansIBA 01/2022
1	ParaffinIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Cyclophilins (Cyclophilin)IBA 01/2017
1	Cyclophilin AIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 06/2015
1	human MIRN665 microRNAIBA 06/2015
1	human MIRN95 microRNAIBA 06/2015
1	Prednisone (Sone)FDA LinkGeneric 11/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014
1	Vincristine (Oncovin)FDA LinkGeneric 11/2014
1	Etoposide (VP 16)FDA LinkGeneric 11/2014
1	Epirubicin (Ellence)FDA LinkGeneric 11/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2017 - 11/2014
2	Parenteral Infusions 01/2017 - 03/2016
1	Immunotherapy 10/2017
1	Therapeutics 03/2016
1	Neoadjuvant Therapy 12/2014
1	VAP-cyclo protocol 11/2014